Video Shorts

FDA Approves First-of-its-Kind Chronic Hepatitis B Treatment

Why AI Transparency is Crucial for Science

The Future of Cancer Treatment: Why Biomarkers Matter

Next in Biologics: FDA Reviews First Keytruda Biosimilar Without Phase 3 Trial

How Surrogate Endpoints Accelerate Patient Access to Innovation

Why Amino-Acid Counting Decides Regulatory Fate

Why Basel is the Global Hub for Immune Engineering

Building the Future of Immune Engineering

How AI and 'Lane Assist' are Transforming Cancer Care

The Core Mission: Translation in Immune Engineering

Why Structure is the Ultimate Risk Management in M&A

How AI Shrinks Clinical Trial Design from Months to Minutes

Can Vaccines Overcome Cancer Immune Suppression?

The Manufacturing Challenge: Scaling Personalized Cancer Treatment

The Billion-Dollar Secret to a Successful Product Launch

How AI is Revolutionizing Clinical Trial Patient Matching

The Future of AI and Predictive Manufacturing in Pharma

How Cancer Vaccines Create a Lifelong Immune 'Police Force'

Why Cancer Vaccines are the Future of Immunotherapy

How Nanophysics is Disrupting Modern Medicine

Confronting Major Challenges Before We Can Cure Type 1 Diabetes_pt.4

Why a Cure for Type 1 Diabetes is Now Inevitable

This Breakthrough Could Cure Type 1 Diabetes

Why Collaboration is Key in Biotech

The Gene Therapy Manufacturing Bottleneck

Why Pharma Abandoned Nature (And How It’s Coming Back)

Real-Time Analytics Could Reshape Process Control in Biomanufacturing

Rethinking Protein Quantitation for the Future of Biomanufacturing

Funding Science Instead of Science Fiction

The Brutal Truth Behind Cancer Drug Funding